 Home > Biochemistry News > Biotechnology News > Sanofi cuts off two early-stage tumor monoclonal antibodies after terminating cooperation with Sangamo cell therapy

Sanofi cuts off two early-stage tumor monoclonal antibodies after terminating cooperation with Sangamo cell therapy

 Last Update: 2022-05-02
 Source: Internet
 Author: User

Tags

cancer cell lines

abc 1 2

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationAspirin

Sanofi axed two more cancer-preventing monoclonal antibodies in Phase 1 clinical trials, weeks after terminating a cell therapy partnership with Sangamo

The large French pharmaceutical company disclosed the axed items during its full-year 2021 earnings call on February 4, 2022

As Sanofi CEO Paul Hudson described in December 2019, the two drug candidates are part of Sanofi's push into the next cycle of its drug development, but the cuts could be nearly as bad for the company's pipeline.

SAR439459, an anti-TGFb therapy

Sanofi's trial entry for SAR442085 was updated on January 14 and listed the trial status as recruiting

The news comes just weeks after Sanofi said it would end its cell therapy agreement with Sangamo

Reference: Sanofi ends 2 phase 1 cancer assets weeks after axing Sangamo deal

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.